Noriday 28: Supply issue resolved
Pfizer have reassured us there is ample stock of Noriday 28 to meet demand.
Information for pharmacists
If you are having difficulty sourcing Noriday 28, contact Pfizer on 0800 736 363(external link)
Previous advice for alternatives to Noriday
PHARMAC has sought clinical advice on suitable funded alternatives available for both contraception and HRT.
Microlut is a fully funded suitable progestogen-only alternative to Noriday. There should be no clinical concern with a change to Microlut from Noriday. Although, a change in bleeding pattern may occur.
Cerazette is also a suitable alternative, however this is not funded.
Family Planning are only offering virtual consultations while we are at Alert Level 4. They provided some contraception guidance to clinicians on appropriate treatments while in lockdown.
Long-acting reversible contraceptives (LARCS) and Depo Provera injection choices may remain options during lockdown by providers other than Family Planning.
Hormone replacement therapy (HRT)
PHARMAC understands that Noriday may be used for HRT when very low doses of estradiol are being prescribed (this is an unapproved indication).
The 5 mg tablet of norethisterone (Primolut N) can be split into quarters. Each quarter will provide a 1.25 mg dose, which will provide appropriate endometrial protection for the majority of estrogen doses.
Medroxyprogesterone acetate (Provera) is another funded alternative.
No additional monitoring should be required with these alternatives unless PV bleeding occurs with the change.
Other contraceptive supply issues
Last updated: 29 May 2020